Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments
- PMID: 29996772
- PMCID: V体育官网入口 - PMC6042259
- DOI: V体育ios版 - 10.1186/s12876-018-0842-7
Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments
Abstract
Background: Previous studies have indicated that bile acid is associated with progression of liver cirrhosis. However, the particular role of specific bile acid in the development of liver cirrhosis is not definite VSports手机版. The present study aims to identify the specific bile acid and explore its possible mechanisms in promoting liver cirrhosis. .
Methods: Thirty two cirrhotic patients and 27 healthy volunteers were enrolled. Age, gender, Child-Pugh classification and serum of patients and volunteers were collected. Liquid chromatography tandem mass spectrometry (LC-MS) was utilized to determine concentrations of 12 bile acids in serum V体育安卓版. Principal component analysis, fold change analysis and heatmap analysis were used to identify the most changed bile acid. And pathway analysis was used to identify the most affected pathway in bile acid metabolism. Spearman rank correlation analysis was employed to assess correlation between concentrations of bile acids and Child-Pugh classification. Hepatic stellate cells (LX-2) were cultured in DMEM. LX-2 cells were also co-cultured with HepG2 cells in the transwell chambers. LX-2 cells were treated with Na+/taurocholate in different concentrations. Western blot was used to evaluate the expression of alpha smooth muscle actin (α-SMA), type I collagen, and Toll-like receptor 4 (TLR4) in LX-2 cells. .
Results: Concentrations of 12 bile acids in serum of patients and healthy volunteers were determined with LC-MS successively. Principal component analysis, fold change analysis and heatmap analysis identified taurocholic acid (TCA) to be the most changed bile acid. Pathway analysis showed that TCA biosynthesis increased significantly. Spearman rank correlation analysis showed that concentration of TCA in serum of cirrhotic patients was positively associated with Child-Pugh classification V体育ios版. TCA increased the expression of α-SMA, type I collagen, and TLR4 in LX-2 cells. Moreover, the above effect was strengthened when LX-2 cells were co-cultured with HepG2 cells. .
Conclusions: Increased TCA concentration in serum of liver cirrhotic patients is mainly due to increased bile acid biosynthesis. TCA is an active promoter of the progression of liver cirrhosis. TCA promoting liver cirrhosis is likely through activating hepatic stellate cells via upregulating TLR4 expression VSports最新版本. TCA is a potential therapeutic target for the prevention and treatment of liver cirrhosis. .
Keywords: Hepatic stellate cell; Liver cirrhosis; Metabolomics; Taurocholic acid V体育平台登录. .
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the Ethics Committee of First Affiliated Hospital of Dalian Medical University (No:LCKY2016–34). And written informed consent was obtained from each cirrhotic patient and healthy volunteer VSports注册入口.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



References
-
- Yonghao G, Jin X, Jun L, Pumei D, Ying Y, Xiuhong F, Yanyang Z, Wanshen G. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in Central China. Int J Infect Dis. 2015;40:75–80. doi: 10.1016/j.ijid.2015.10.002. - V体育2025版 - DOI - PubMed
-
- Axelson M, Ellis E, Mörk B, Garmark K, Abrahamsson A, Björkhem I, Ericzon BG, Einarsson C. Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid. Hepatology. 2000;31(6):1305–1312. doi: 10.1053/jhep.2000.7877. - "V体育2025版" DOI - PubMed
"V体育安卓版" MeSH terms
- "V体育官网" Actions
- Actions (V体育官网入口)
- "VSports注册入口" Actions
- V体育官网入口 - Actions
- Actions (VSports最新版本)
- VSports - Actions
- "V体育官网入口" Actions
Substances
- "VSports" Actions
- Actions (VSports在线直播)
- "V体育安卓版" Actions
Grants and funding (V体育官网入口)
LinkOut - more resources
"V体育官网入口" Full Text Sources
Other Literature Sources
Medical
Miscellaneous (V体育ios版)